Cargando…
Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement
Erdheim-Chester disease (ECD) is a rare form of non–Langerhans cell histiocytosis characterized by infiltration of organs by CD68(+) and CD1a(−) lipid-laden histiocytes, including the central nervous system in more than a third of patients. Molecular analysis of ECD samples has demonstrated the prev...
Autores principales: | Al Bayati, Ahmed, Plate, Thomas, Al Bayati, Mahmood, Yan, Yaohong, Lavi, Efrat Saraf, Rosenblatt, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132217/ https://www.ncbi.nlm.nih.gov/pubmed/30225465 http://dx.doi.org/10.1016/j.mayocpiqo.2018.05.001 |
Ejemplares similares
-
Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib
por: Salama, Hind, et al.
Publicado: (2022) -
Neurological Involvement in Erdheim-Chester Disease
por: Álvarez-Álvarez, Miriam, et al.
Publicado: (2016) -
P1043: EFFICACY AND SAFETY OF TRAMETINIB IN ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS AND ERDHEIM-CHESTER DISEASE
por: Latyshev, Vitalii, et al.
Publicado: (2023) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
Isolated pulmonary involvement in Erdheim–Chester disease
por: Josan, Enambir Singh, et al.
Publicado: (2017)